Frank Curzio's WALL STREET UNPLUGGED Podcast

Ep. 325 – Frankly Speaking: INO, Buy or Sell Side Analysts, Reverse ETF’s and Stops

We start today with three questions from Clark. First, he asks about the difference between buy-side and sell-side analysts.

Second, he’d like to know about why and when companies release their earnings reports.

And third, he’d like to know about my special offer.

[app_audio src=”″]

TJ wrote in to ask about the pharmaceutical company Inovio Pharmaceuticals, Inc. (INO) and to get my opinion on Tim Sykes.

Steve would like my opinion on reverse ETF’s if the market does come down.

Then Robert writes in to comment on biases in research and to ask  about the risks of setting stops.

Finally, Agustin has a question about a penny stock he’s interested in. They’ve received a government contract recently and he wants to know if it’s smart to put a $1000 into a stock like this and hope for the best.

As always, thanks for listening and good investing!


investing mistake

My biggest investing mistake

I talk about my successes on the podcast… but I also share my #fails. Not just for the sake of transparency, but for the sake…
Listen Now
tech disruptors

The next big tech disruptors... And why the biggest story out of China is complete B.S.

Chris Wood, chief investment officer at Riskhedge and respected tech analyst, joins me to discuss the buzz around 5G... and how this incredible growth trend…
Listen Now